Comment on "Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects".
Main Authors: | Handel, A, Luca, D, Ramagopalan, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
THE PRODUCTION OF 1,25-DIHYDROXYVITAMIN-D IN PRIMARY HYPERPARATHYROIDISM
by: Thakker, R, et al.
Published: (1986) -
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis.
by: Wingerchuk, D, et al.
Published: (2005) -
Gender differences in 1,25-dihydroxyvitamin D3 effects on osteoclast formation from circulating and bone marrow precursors.
by: Jevon, M, et al.
Published: (2001) -
Circulating concentrations of 1,25-dihydroxyvitamin D3 in patients with primary hyperparathyroidism.
by: Thakker, R, et al.
Published: (1986) -
The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro.
by: Beresford, J, et al.
Published: (1994)